Group 1 - The company, Giant Bio (02367), announced a share buyback plan, intending to repurchase 400,000 shares at a cost of HKD 13.883 million [1]

表格類別： 股票 狀態： 新提交 公司名稱： 巨子生物控股有限公司 呈交日期： 2025年12月18日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02367 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | | ...

Core Viewpoint - The collagen market is undergoing significant changes with the approval of new products from Chongshan Bio and Aibai Rui, expanding the competitive landscape in the animal-derived collagen sector. The focus is shifting towards differentiation in terms of cost-effectiveness, brand recognition, product safety, and efficacy as the market becomes increasingly crowded [1][2]. Group 1: New Product Approvals - Chongshan Bio's new product is the world's first collagen implant with a concentration of 45mg/ml, aiming to establish a strong product image through high concentration [2]. - Aibai Rui's new product targets specific needs by improving cheek smoothness, attempting to create a niche in the market despite similarities to existing products [4]. Group 2: Market Dynamics - The animal-derived collagen market has formed an "eight strong" competitive landscape, with established players like Shuangmei Bio leading the market due to their early entry and established brand recognition [6]. - New entrants are focusing on differentiation strategies, such as high-quality ingredients and innovative product forms, to compete effectively [6]. Group 3: Growth of Recombinant Collagen - The recombinant collagen market is experiencing rapid growth, with a projected compound annual growth rate (CAGR) of 41.4% from 2023 to 2027, surpassing the 27.7% CAGR of animal-derived collagen [8]. - The market size for recombinant collagen products in 2023 is estimated at 28.63 billion yuan, slightly below the 29.79 billion yuan for animal-derived collagen, indicating a shift in consumer preference towards recombinant options [8]. Group 4: Competitive Landscape and Future Outlook - The approval of new recombinant collagen products is intensifying competition, with companies like Jinjian Bio and others entering the market, challenging the previous dominance of Jinbo Bio [9]. - The future of the collagen market will likely see increased competition, with a focus on cost-effectiveness, brand strength, and product efficacy becoming critical for success [12].

Market Overview - The Hong Kong stock market experienced low-level fluctuations influenced by a collective decline in US tech stocks, with the Hang Seng Index closing up 0.12% at 25,498.13 points, while the Hang Seng Tech Index fell 0.73% to 5,418.29 points [1] - Major tech stocks showed mixed performance, with Alibaba down 1.3%, JD Group down 0.09%, and Xiaomi down 2.47%, while NetEase, Meituan, Kuaishou, and Bilibili saw slight gains [1] - Airline stocks continued to rise, with China Eastern Airlines increasing by over 7%, while coal stocks strengthened in the afternoon, with Huayi Resources up over 9% [1] - Lithium battery stocks faced significant declines, with CATL down over 3%, and new consumption concept stocks weakened, with Miniso down over 3% [1] Company News - Ronshine China reported a total contract sales of approximately 3.492 billion yuan in the first 11 months, reflecting a year-on-year decline [2] - Corning Jereh Pharmaceutical's IND application for JSKN027 has been officially accepted by the CDE [2] - Yanda Pharmaceutical's globally innovative radiopharmaceutical GPN01530 has been approved for clinical research in the US [2] - Harmony Auto's subsidiary iCar Group Limited may engage new investors for further equity financing, involving 40 million USD [2] - China CRRC signed significant contracts totaling approximately 53.31 billion yuan over the past three months [3] - Minth Group entered into a strategic cooperation agreement with a robotics company [4] - Xunce began its IPO subscription today, offering 22.5 million H-shares [5] Stock Buybacks - Budweiser APAC appointed Bernardo Novick as CFO, effective April 1, 2026 [6] - China Metallurgical Group plans to repurchase up to 2 billion yuan of A-shares and 500 million yuan of H-shares [7] - Kuaishou repurchased 1.283 million shares for 83.037 million HKD at prices ranging from 63.9 to 65.55 HKD [8] - Tencent repurchased 1.057 million shares for 636 million HKD at prices between 595 and 605.5 HKD [9] - Techtronic Industries repurchased 500,000 shares for 44.91 million HKD at prices from 89.35 to 90.50 HKD [10] - Country Garden Services repurchased 3.697 million shares for 23.1748 million HKD at prices between 6.22 and 6.33 HKD [11] - Giga Bio repurchased 400,000 shares for 13.9713 million HKD at prices from 34.62 to 35.22 HKD [12] Institutional Insights - According to China Merchants Securities, the recent weakness in the Hong Kong market is attributed to southbound capital returning to A-shares due to new public fund benchmark regulations, concerns over IPO financing, and an upcoming peak in unlocks, alongside profit downgrades and overseas liquidity disturbances [13] - Huatai Securities noted that while the market's downside is manageable, the upside potential remains limited, with sentiment indicators still in a pessimistic range [13] - Ping An International expects the market to maintain a volatile stance in the short term, with potential rotation in investment styles and main lines [14] - Jianyin International suggests buying on dips before the spring market in early 2025, focusing on high-yield stocks and sectors like technology, high-end manufacturing, and new energy [14]

Summary of Key Points from Conference Call Records Industry Overview - The conference call discusses the **large consumption sector**, highlighting the emergence of new consumer demands that drive growth in the sector through new products (personalized, green, low-carbon), new channels (snack chains, discount formats), and new business models (diverse consumption scenarios) supported by the "14th Five-Year Plan" [1][2]. Core Insights and Arguments - **Traditional Consumption Recovery**: The traditional consumption sector is expected to recover by 2026, driven by the release of residents' purchasing power and policy measures aimed at boosting employment and income stability. The food and beverage industry is stabilizing, with the liquor sector showing signs of fundamental stability and dairy products expected to recover quickly [1][5]. - **Commodity Market Trends**: The commodity market has shown a trend of high followed by low prices, with the government implementing various promotional policies to stimulate service consumption and domestic demand. The Ministry of Commerce has issued opinions to expand service consumption, aiming to enhance residents' quality of life and stimulate domestic demand potential [1][6][7]. - **Emerging Consumer Demands**: New consumer demands are impacting the large consumption sector through three main directions: the development of new products that meet diverse and personalized needs, the optimization of new channel structures, and the promotion of new business models that foster diverse consumption scenarios [2][4]. Important but Overlooked Content - **Social Services Sector Changes**: The social services sector is evolving to meet changing consumer demands, with slight increases in beauty care and retail sectors. Key areas of investment include outdoor sports, gold and jewelry, and cultural and trendy IPs, with recommendations for companies like Anta Sports and Lao Pu Gold [8][22]. - **Tourism Market Trends**: The tourism market is gradually recovering, with leading companies like Ctrip and Huazhu Group adapting through technological innovation and marketing to meet the new demands of both young and elderly consumers. China Duty Free's Hainan business has benefited significantly from new duty-free policies [9][10]. - **Food and Beverage Sector Stability**: The food and beverage sector is stabilizing, with the liquor market facing challenges but showing resilience in mass consumption. The snack sector is experiencing performance differentiation, while dairy product demand is steady and supply is gradually clearing [12][17]. - **Investment Opportunities in Agriculture**: The agriculture, forestry, animal husbandry, and fishery sectors present investment opportunities, particularly in pig farming and the pet industry, which is growing due to demographic changes and emotional needs [3][13][19]. - **Household Appliance Sector**: The household appliance industry is seeking structural highlights amid steady growth, with a focus on high-dividend white goods and improving profit margins in black goods. The market for robotic vacuum cleaners is also expected to grow due to technological advancements [20][21]. This summary encapsulates the key points discussed in the conference call, providing insights into the large consumption sector and its various components, along with potential investment opportunities and market trends.

自12月9日以来公司已连续7日进行回购，合计回购280.00万股，累计回购金额9859.74万港元。 其间该 股累计下跌3.57%。（数据宝） 证券时报·数据宝统计，巨子生物在港交所公告显示，12月17日以每股34.620港元至35.220港元的价格回 购40.00万股，回购金额达1397.13万港元。该股当日收盘价35.100港元，上涨1.09%，全天成交额1.62亿 港元。 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.12.17 | 40.00 | 35.220 | 34.620 | 1397.13 | | 2025.12.16 | 40.00 | 35.400 | 34.680 | 1402.61 | | 2025.12.15 | 40.00 | 35.240 | 34.440 | 1391.73 | | 2025.12.12 | 40.00 | 35.220 | 35.000 | 1403.64 | | 2025.12.11 | 40.00 | 35.360 | ...

巨子生物(02367)发布公告，于2025年12月17日该公司斥资1397.13万港元回购40万股，回购价格为每股 34.62-35.22港元。 ...

智通财经APP讯，巨子生物(02367)发布公告，于2025年12月17日该公司斥资1397.13万港元回购40万 股，回购价格为每股34.62-35.22港元。 ...

格隆汇12月17日丨巨子生物(02367.HK)公告，12月17日耗资1397.1万港元回购40万股。 ...

表格類別： 股票 狀態： 新提交 公司名稱： 巨子生物控股有限公司 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 呈交日期： 2025年12月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02367 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | 事件 | 已發行股份（不包括庫存股份）數 目 ...